A clinical research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and international genetic researchers led a global research study using multi-omics analysis and ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies ... AdvanCell to rapidly develop and progress novel Pb-212-containing radiotherapeutics from ...

Endoscopic ultrasound-guided radiofrequency ablation can offer an effective alternative to traditional surgery in treating ...

Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...

Thanks to the rising demand for targeted therapies. The global personalised medicine biomarkers market is projected to reach ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

Triple T, a new minimally invasive therapy, could replace adrenal surgery for treating primary aldosteronism, a hidden cause ...